Cargando…

An integrative systems biology approach to overcome venetoclax resistance in acute myeloid leukemia

The over-expression of the Bcl-2 protein is a common feature of many solid cancers and hematological malignancies, and it is typically associated with poor prognosis and resistance to chemotherapy. Bcl-2-specific inhibitors, such as venetoclax, have recently been approved for the treatment of chroni...

Descripción completa

Detalles Bibliográficos
Autores principales: Przedborski, Michelle, Sharon, David, Cathelin, Severine, Chan, Steven, Kohandel, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469948/
https://www.ncbi.nlm.nih.gov/pubmed/36099249
http://dx.doi.org/10.1371/journal.pcbi.1010439